VCYT

Veracyte, Inc.

1 day chart

About VCYT

Veracyte, Inc. is a global diagnostics company. The Company is engaged in the development and commercialization of diagnostic products and biopharmaceutical services. It offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder). Its Percepta Nasal Swab test is being run in its Clinical Laboratory Improvement Amendments (CLIA) lab in support of clinical studies and its tests for kidney cancer and lymphoma are in development, the latter as a companion diagnostic. It also offers an Immunogram, which provides an understanding of the tumor immune microenvironment by integrating data from a variety of genomic, transcriptomic, and proteomic platforms. Its tests in the United States are serviced through its own CLIA-certified laboratories in South San Francisco and San Diego, California and Austin, Texas. It also offers customized biomarker testing and analytical services.

Buy US stocks in Australia starting with VCYT. Open an account and start investing today!

Market Capitalisation

$1.83B

Price-earnings ratio

Dividend yield

0.00%

Volume

1.5M

High today

$25.36

Low today

$24.72

Open price

$25.25

52-week high

$32.40

52-week low

$14.92

VCYT FAQs

Can I buy VCYT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy VCYT shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Veracyte, Inc.?

One share of Veracyte, Inc. is valued at $26.23.

What is the ticker symbol for Veracyte, Inc.?

The ticker symbol for Veracyte, Inc. is VCYT.

How do I buy VCYT shares in Australia?

To buy VCYT stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in VCYT

What is the 52-week high for Veracyte, Inc. stock?

The Veracyte, Inc. 52-week high stock price is $32.40.

What is the 52-week low for Veracyte, Inc. stock?

The Veracyte, Inc. 52-week low stock price is $14.92.

What is the market capitalisation of Veracyte, Inc. VCYT?

As of 16/09/2023 Veracyte, Inc. has a market cap of $1.8B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.